急性早幼粒细胞白血病患者合并弥散性血管内凝血的影响因素及列线图模型构建
杨柳， 梁晶晶， 董春霞， 康建民， 郭丽萍， 赵蛟宇… - 临床血液学 …, 2023 - lcxy.whuhzzs.com
目的探讨急性早幼粒细胞白血病(APL) 合并弥散性血管内凝血(DIC) 的影响因素, 建立初诊APL
患者发生DIC 风险的预测模型, 为临床诊治提供参考. 方法回顾性分析单中心179 例初诊APL …
患者发生DIC 风险的预测模型, 为临床诊治提供参考. 方法回顾性分析单中心179 例初诊APL …
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen …
S Kungwankiattichai, W Owattanapanich… - …, 2023 - Taylor & Francis
Introduction Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid
leukemia (AML) with a unique clinical presentation and prognosis. This study aimed to …
leukemia (AML) with a unique clinical presentation and prognosis. This study aimed to …
[HTML][HTML] 20 (S)-ginsenoside Rh2 ameliorates ATRA resistance in APL by modulating lactylation-driven METTL3
S Cheng, L Chen, J Ying, Y Wang, W Jiang… - Journal of Ginseng …, 2024 - Elsevier
Abstract Background 20 (S)-ginsenoside Rh2 (GRh2), an effective natural histone
deacetylase inhibitor, can inhibit acute myeloid leukemia (AML) cell proliferation. Lactate …
deacetylase inhibitor, can inhibit acute myeloid leukemia (AML) cell proliferation. Lactate …
儿童急性早幼粒细胞白血病早期死亡危险因素分析
姚强华， 王颖超， 王叨， 刘玉峰 - 临床儿科杂志, 2024 - jcp.xinhuamed.com.cn
目的分析初诊急性早幼粒细胞白血病(APL) 早期死亡患儿的临床特点, 探讨直接死亡原因和导致
早期死亡的危险因素. 方法回顾性分析2013 年1 月至2020 年12 月连续收治的初诊APL …
早期死亡的危险因素. 方法回顾性分析2013 年1 月至2020 年12 月连续收治的初诊APL …
Analysis of influencing factors and establish of nomogram model of disseminated intravascular coagulation in patients with acute promyelocytic leukemia
Y Liu, L Jingjing, D Chunxia, K Jianmin… - J Clin …, 2023 - lcxyen.whuhzzs.com
To investigate the clinical features and risk factors of acute promyelocytic leukemia (APL)
complicated with disseminated intravascular coagulation (DIC), and to establish a predictive …
complicated with disseminated intravascular coagulation (DIC), and to establish a predictive …